Saturday, July 01, 2017 5:32:38 PM
re an earlier post re company's arthritis PR of 6/29 and your reply to it: yes...theralase's PDT Cancer treatment is the big potential breakout story here, surely why most are here. But the arthritis pain/inflammation control market is itself a potential multi-billion $$ opportunity for the laser division....IF company can capitalize on it. Unclear from that PR what regulatory hoops company would have to clear to move this forward...or how company intends to address this. Would like to see more specifics re this as it seems, at least on the surface, a market for the 2000 well worth pursuing....
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM